Suppr超能文献

经皮冠状动脉介入治疗期间冠状动脉斑块旋切术后年龄与不良事件的相关性。

Association of age with adverse events following coronary atherectomy during percutaneous coronary intervention.

作者信息

Park Dae Yong, Hu Jiun-Ruey, DeAngelo Sean, Vij Aviral, Jamil Yasser, Babapour Golsa, Akman Zafer, Pazooki Parsa, Damluji Abdulla A, DO Jennifer Frampton, Li Darrick K, Nanna Michael G

机构信息

Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, USA.

Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

出版信息

J Geriatr Cardiol. 2025 May 28;22(5):497-505. doi: 10.26599/1671-5411.2025.05.007.

Abstract

BACKGROUND

Coronary atherectomy is used to treat severely calcified coronary artery lesions which are more frequent with increasing age, but its impact in older adults has not been sufficiently examined.

METHODS

We compared adults ≥ 18 years old who underwent coronary atherectomy during inpatient PCI in 2016-2023 from the Vizient Clinical Data Base and compared outcomes in younger (< 65 years), youngest-old (65-74 years), middle-old (75-84 years), and oldest-old (≥ 85 years) adults. Primary outcome was in-hospital mortality, and secondary outcomes included postprocedural complications.

RESULTS

Among 47,337 patients who underwent coronary atherectomy, 19,862 (42.0%) were younger adults and 27,475 (58.0%) were older adults, including 13,583 youngest-old, 10,206 middle-old, and 3,686 oldest-old adults. Compared with younger adults, youngest-old adults had higher mortality (adjusted odds ratio [aOR] = 1.37, < 0.001), ischemic stroke (aOR = 1.35, = 0.005), gastrointestinal hemorrhage (GIH) (aOR = 1.44, < 0.001), acute kidney injury (AKI) (aOR = 1.43, < 0.001), tamponade (aOR = 1.86, < 0.001), and pericardiocentesis (aOR = 2.32, < 0.001). Middle-old adults had higher mortality (aOR = 1.80, < 0.001), GIH (aOR = 1.42, = 0.002), AKI (aOR = 1.63, < 0.001), tamponade (aOR = 2.52, < 0.001), and pericardiocentesis (aOR = 3.13, < 0.001). Oldest-old adults had the highest odds for mortality (aOR = 2.03, < 0.001), GIH (aOR = 1.48, = 0.016), AKI (aOR = 2.26, < 0.001), tamponade (aOR = 3.86, < 0.001), and pericardiocentesis (aOR = 4.21, < 0.001). There was a significant interaction (P-interaction=0.035) between atherectomy and age groups with regard to the odds of in-hospital mortality.

CONCLUSIONS

In this large claims-based study, in-hospital mortality, GIH, AKI, tamponade, and pericardiocentesis were higher in older adults compared with younger adults, in a stepwise manner by age group.

摘要

背景

冠状动脉旋切术用于治疗严重钙化的冠状动脉病变,此类病变随年龄增长更为常见,但其对老年人的影响尚未得到充分研究。

方法

我们比较了2016年至2023年期间在Vizient临床数据库中住院接受PCI时接受冠状动脉旋切术的18岁及以上成年人,并比较了年轻(<65岁)、最年轻的老年人(65 - 74岁)、中年老年人(75 - 84岁)和最年长的老年人(≥85岁)的结局。主要结局是住院死亡率,次要结局包括术后并发症。

结果

在47337例接受冠状动脉旋切术的患者中,19862例(42.0%)为年轻人,27475例(58.0%)为老年人,其中包括13583例最年轻的老年人、10206例中年老年人和3686例最年长的老年人。与年轻人相比,最年轻的老年人死亡率更高(调整优势比[aOR]=1.37,P<0.001)、缺血性卒中(aOR = 1.35,P = 0.005)、胃肠道出血(GIH)(aOR = 1.44,P<0.001)、急性肾损伤(AKI)(aOR = 1.43,P<0.001)、心包填塞(aOR = 1.86,P<0.001)和心包穿刺术(aOR = 2.32,P<0.001)。中年老年人死亡率更高(aOR = 1.80,P<0.001)、GIH(aOR = 1.42,P = 0.002)、AKI(aOR = 1.63,P<0.001)、心包填塞(aOR = 2.52,P<0.001)和心包穿刺术(aOR = 3.13,P<0.001)。最年长的老年人死亡率(aOR = 2.03,P<0.001)、GIH(aOR = 1.48,P = 0.016)、AKI(aOR = 2.26,P<0.001)、心包填塞(aOR = 3.86,P<0.001)和心包穿刺术(aOR = 4.21,P<0.001)的优势比最高。冠状动脉旋切术与年龄组之间在住院死亡率的优势比方面存在显著交互作用(P交互作用=0.035)。

结论

在这项基于大量索赔数据的研究中,与年轻人相比,老年人的住院死亡率、GIH、AKI、心包填塞和心包穿刺术更高,且随年龄组呈逐步上升趋势。

相似文献

1
Association of age with adverse events following coronary atherectomy during percutaneous coronary intervention.
J Geriatr Cardiol. 2025 May 28;22(5):497-505. doi: 10.26599/1671-5411.2025.05.007.
3
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3.
4
Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 10;4(4):CD013155. doi: 10.1002/14651858.CD013155.pub2.
5
Intravenous immunoglobulin for the treatment of Kawasaki disease.
Cochrane Database Syst Rev. 2023 Jan 25;1(1):CD014884. doi: 10.1002/14651858.CD014884.pub2.
6
Percutaneous transluminal rotational atherectomy for coronary artery disease.
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD003334. doi: 10.1002/14651858.CD003334.pub2.
10
Exercise-based cardiac rehabilitation for coronary heart disease.
Cochrane Database Syst Rev. 2021 Nov 6;11(11):CD001800. doi: 10.1002/14651858.CD001800.pub4.

本文引用的文献

1
Case Volumes and Outcomes Among Early-Career Interventional Cardiologists in the United States.
J Am Coll Cardiol. 2024 May 21;83(20):1990-1998. doi: 10.1016/j.jacc.2024.03.395.
2
Chronological vs Biological Age in Interventional Cardiology: A Comprehensive Approach to Care for Older Adults: JACC Family Series.
JACC Cardiovasc Interv. 2024 Apr 22;17(8):961-978. doi: 10.1016/j.jcin.2024.01.284. Epub 2024 Apr 8.
3
4
Assessment and Management of Older Adults Undergoing PCI, Part 1: A Expert Panel.
JACC Adv. 2023 Jun;2(4). doi: 10.1016/j.jacadv.2023.100389.
5
Rotablation for Octogenarians in a Modern Cathlab: Short- and Intermediate-Term Results.
Acta Cardiol Sin. 2023 May;39(3):424-434. doi: 10.6515/ACS.202305_39(3).20220926B.
6
Sex difference in clinical and procedural outcomes in patients undergoing coronary atherectomy: a systematic review and meta-analysis.
Coron Artery Dis. 2022 Dec 1;33(8):634-642. doi: 10.1097/MCA.0000000000001187. Epub 2022 Oct 17.
7
Successful Off-Label Use of Rotational Atherectomy in ST-Segment Elevation Myocardial Infarction: A Case Report.
Cardiovasc Revasc Med. 2022 Jul;40S:272-275. doi: 10.1016/j.carrev.2021.11.014. Epub 2021 Nov 14.
8
Calcium Modification Techniques in Complex Percutaneous Coronary Intervention.
Circ Cardiovasc Interv. 2021 May;14(5):e009870. doi: 10.1161/CIRCINTERVENTIONS.120.009870. Epub 2021 Jan 14.
9
Arterial Stiffness and Hypertension in the Elderly.
Front Cardiovasc Med. 2020 Oct 29;7:544302. doi: 10.3389/fcvm.2020.544302. eCollection 2020.
10
Effects of aging on coronary flow reserve in patients with no evidence of myocardial perfusion abnormality.
Heart Vessels. 2020 Dec;35(12):1633-1639. doi: 10.1007/s00380-020-01643-8. Epub 2020 Jun 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验